Akaihata, H.; Matsuoka, K.; Hata, J.; Harigane, Y.; Yaginuma, K.; Endo, Y.; Imai, H.; Matsuoka, Y.; Onagi, A.; Tanji, R.;
et al. Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat. Int. J. Mol. Sci. 2023, 24, 3982.
https://doi.org/10.3390/ijms24043982
AMA Style
Akaihata H, Matsuoka K, Hata J, Harigane Y, Yaginuma K, Endo Y, Imai H, Matsuoka Y, Onagi A, Tanji R,
et al. Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat. International Journal of Molecular Sciences. 2023; 24(4):3982.
https://doi.org/10.3390/ijms24043982
Chicago/Turabian Style
Akaihata, Hidenori, Kanako Matsuoka, Junya Hata, Yuki Harigane, Kei Yaginuma, Yu Endo, Hitomi Imai, Yuta Matsuoka, Akifumi Onagi, Ryo Tanji,
and et al. 2023. "Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat" International Journal of Molecular Sciences 24, no. 4: 3982.
https://doi.org/10.3390/ijms24043982
APA Style
Akaihata, H., Matsuoka, K., Hata, J., Harigane, Y., Yaginuma, K., Endo, Y., Imai, H., Matsuoka, Y., Onagi, A., Tanji, R., Honda-Takinami, R., Hoshi, S., Koguchi, T., Sato, Y., Kataoka, M., Uemura, M., Igawa, Y., & Kojima, Y.
(2023). Involvement of Mast-Cell-Tryptase- and Protease-Activated Receptor 2—Mediated Signaling and Urothelial Barrier Dysfunction with Reduced Uroplakin II Expression in Bladder Hyperactivity Induced by Chronic Bladder Ischemia in the Rat. International Journal of Molecular Sciences, 24(4), 3982.
https://doi.org/10.3390/ijms24043982
